Watkins_2017_J.Pharm.Sci_106_906

Reference

Title : Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate - Watkins_2017_J.Pharm.Sci_106_906
Author(s) : Watkins ME , Wring S , Randolph R , Park S , Powell K , Lutz L , Nowakowski M , Ramabhadran R , Domanico PL
Ref : J Pharm Sci , 106 :906 , 2017
Abstract : Watkins_2017_J.Pharm.Sci_106_906
ESTHER : Watkins_2017_J.Pharm.Sci_106_906
PubMedSearch : Watkins_2017_J.Pharm.Sci_106_906
PubMedID: 27986599

Related information

Citations formats

Watkins ME, Wring S, Randolph R, Park S, Powell K, Lutz L, Nowakowski M, Ramabhadran R, Domanico PL (2017)
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate
J Pharm Sci 106 :906

Watkins ME, Wring S, Randolph R, Park S, Powell K, Lutz L, Nowakowski M, Ramabhadran R, Domanico PL (2017)
J Pharm Sci 106 :906